Abstract:Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and cardiac fibrosis. Emerging evidence indicated that endothelial-to-mesenchymal transition (Endo-MT) is a crucial event during organ fibrosis. This study was performed to clarify whether Endo-MT contributed to the progression of cardiac fibrosis in DCM. Cardiac samples from patients with DCM and control were obtained. The presence of endothelial markers, cluster of differentiation (CD)31 and vascular endothelial (VE)-cadherin, and mesenchymal markers, smooth muscle actin (SMA) and fibroblast-specific protein 1 (FSP1) was performed using immunohistochemistry. Co-localization of endothelial markers and mesenchymal markers were identified using confocal immunofluorescence staining. Serum procollagen type I carboxy-terminal propeptide (PICP) and procollagen type III amino-terminal propeptide (PIIINP) were measured by ELISA. Protein levels of Wnt, -catenin and Snail were determined using western blot analysis. Immunohistochemistry and double-immunofluorescence staining demonstrated that the expression of CD31 and VE-cadherin were significantly decreased in DCM samples, whereas the FSP-1, and SMA were significantly increased. CD31 and VE-cadherin labeling indexes were respectively negatively correlated with left ventricular end-diastolic diameter (LVEDD) (CD31 r=-0.82, P<0.01; VE-cadherin r=-0.73, P<0.01), while FSP-1 and SMA were positively associated with LVEDD (SMA r=0.65, P<0.01, FSP1 r=0.53, P<0.01) and left ventricular ejection fraction (SMA r=-0.18, P<0.05; FSP1 r=-0.21, P<0.05). Furthermore, PICP and PIIINP levels were positively associated with the co-expression labeling indexes (CD31/SMA co-labeling index and PICP r=0.727, P<0.01; CD31/SMA co-labeling index and PIIINP r=0.741, P<0.01; VE-Cadherin/FSP-1 co-labeling index and PICP r=0.716, P<0.01; VE-cadherin/FSP-1 co-labeling index and PIIINP r=0.648, P<0.05). Western blot analysis indicated that proteins levels of Wnt signaling and snail were significantly increased in DCM samples. These results suggested that Endo-MT is potentially implicated in the pathogenesis of myocardial fibrosis and remodeling during the development of DCM, indicating a potential therapeutic target for DCM treatment.

Abnormal expression of cytoskeletal proteins in patients with dilated cardiomyopathy

Abnormal myocardial cytoskeletal proteins in patients with end-stage dilated cardiomyopathy

[The Expression of Connexin 43 and Desmin in Viral Myocarditis].

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Transcriptome Analysis Uncovers the Autophagy‐mediated Regulatory Patterns of the Immune Microenvironment in Dilated Cardiomyopathy

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Expression and Significance of Coxsackie-Adenovirus Receptor in Myocardia With Dilated Cardiomyopathy

Immune cells and related cytokines in dilated cardiomyopathy

Relationship Between Cathepsin L and Dilated Cardiomyopathy

Expression of CAR in Myocardial of Viral Myocarditis and Dilated Cardiomyopathy

SnRNA-seq reveals differential functional transcriptional pathway alterations in three mutant types of dilated cardiomyopathy

The Expression of Chromogranin A in Dilated Cardiomyopathy

Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments

The Molecular Role of Immune Cells in Dilated Cardiomyopathy

Abstract MP216: Identification Of Novel Phosphoprotein Signaling Pathways In Human Dilated Cardiomyopathy By Integrative Proteomic And Phosphoproteomic Analysis

[The Expression and Significance of Myocardial Cathepsin L in Dilated Cardiomyopathy].

Endothelial‑to‑mesenchymal transition in human idiopathic dilated cardiomyopathy.

Myocardial histopathologic features of end-stage cardiac dieases in 15 cases

A Preliminary Study on the Relationship Between Cathepsin B and Dilated Cardiomyopathy

Myocardial Ischemia In Patients With Dilated Cardiomyopathy

[Association Between Expression of Chromogranin A and Myocardial Fibrosis in Patients with Dilated Cardiomyopathy].